Literature DB >> 25232247

Early detection and prevention of pancreatic cancer: is it really possible today?

Marco Del Chiaro1, Ralf Segersvärd1, Matthias Lohr1, Caroline Verbeke1.   

Abstract

Pancreatic cancer is the 4(th) leading cause of cancer-related death in Western countries. Considering the low incidence of pancreatic cancer, population-based screening is not feasible. However, the existence of a group of individuals with an increased risk to develop pancreatic cancer has been well established. In particular, individuals suffering from a somatic or genetic condition associated with an increased relative risk of more than 5- to 10-fold seem to be suitable for enrollment in a surveillance program for prevention or early detection of pancreatic cancer. The aim of such a program is to reduce pancreatic cancer mortality through early or preemptive surgery. Considering the risk associated with pancreatic surgery, the concept of preemptive surgery cannot consist of a prophylactic removal of the pancreas in high-risk healthy individuals, but must instead aim at treating precancerous lesions such as intraductal papillary mucinous neoplasms or pancreatic intraepithelial neoplasms, or early cancer. Currently, results from clinical trials do not convincingly demonstrate the efficacy of this approach in terms of identification of precancerous lesions, nor do they define the outcome of the surgical treatment of these lesions. For this reason, surveillance programs for individuals at risk of pancreatic cancer are thus far generally limited to the setting of a clinical trial. However, the acquisition of a deeper understanding of this complex area, together with the increasing request for screening and treatment by individuals at risk, will usher pancreatologists into a new era of preemptive pancreatic surgery. Along with the growing demand to treat individuals with precancerous lesions, the need for low-risk investigation, low-morbidity operation and a minimally invasive approach becomes increasingly pressing. All of these considerations are reasons for preemptive pancreatic surgery programs to be undertaken in specialized centers only.

Entities:  

Keywords:  Cystic tumors of the pancreas; Early detection; Familial pancreatic cancer; Pancreas cancer screening; Preemptive pancreatic surgery

Mesh:

Year:  2014        PMID: 25232247      PMCID: PMC4161798          DOI: 10.3748/wjg.v20.i34.12118

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  124 in total

1.  Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.

Authors:  Marco Del Chiaro; Alessandro Zerbi; Gabriele Capurso; Giuseppe Zamboni; Patrick Maisonneuve; Silvano Presciuttini; Paolo Giorgio Arcidiacono; Lucia Calculli; Massimo Falconi
Journal:  Dig Liver Dis       Date:  2010-06-02       Impact factor: 4.088

Review 2.  The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.

Authors:  Mireille Broeders; Sue Moss; Lennarth Nyström; Sisse Njor; Håkan Jonsson; Ellen Paap; Nathalie Massat; Stephen Duffy; Elsebeth Lynge; Eugenio Paci
Journal:  J Med Screen       Date:  2012       Impact factor: 2.136

3.  Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study.

Authors:  Christine N Manser; Lucas M Bachmann; Jakob Brunner; Fritz Hunold; Peter Bauerfeind; Urs A Marbet
Journal:  Gastrointest Endosc       Date:  2012-04-11       Impact factor: 9.427

Review 4.  Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia.

Authors:  Richard F Heitmiller
Journal:  Langenbecks Arch Surg       Date:  2003-02-20       Impact factor: 3.445

5.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

6.  Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Authors:  Noboru Ideno; Takao Ohtsuka; Hiroshi Kono; Kenji Fujiwara; Yasunori Oda; Shinichi Aishima; Tetsuhide Ito; Kousei Ishigami; Shoji Tokunaga; Kenoki Ohuchida; Shunichi Takahata; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

7.  The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Authors:  J W Poley; I Kluijt; D J Gouma; F Harinck; A Wagner; C Aalfs; C H J van Eijck; A Cats; E J Kuipers; Y Nio; P Fockens; M J Bruno
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

8.  Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.

Authors:  Irene Esposito; Christopher Seiler; Frank Bergmann; Jörg Kleeff; Helmut Friess; Peter Schirmacher
Journal:  Pancreas       Date:  2007-10       Impact factor: 3.327

9.  Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis. Early and late results.

Authors:  H G Beger; M Büchler; R R Bittner; W Oettinger; R Roscher
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

10.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335

View more
  36 in total

1.  Cystic tumors of the pancreas: Opportunities and risks.

Authors:  Marco Del Chiaro; Caroline Verbeke
Journal:  World J Gastrointest Pathophysiol       Date:  2015-05-15

2.  CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jayasree Chakraborty; Abhishek Midya; Lior Gazit; Marc Attiyeh; Liana Langdon-Embry; Peter J Allen; Richard K G Do; Amber L Simpson
Journal:  Med Phys       Date:  2018-09-27       Impact factor: 4.071

Review 3.  Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.

Authors:  Ajaykumar C Morani; Abdelrahman K Hanafy; Nisha S Ramani; Venkata S Katabathina; Sireesha Yedururi; Anil K Dasyam; Srinivasa R Prasad
Journal:  Radiol Imaging Cancer       Date:  2020-03-13

Review 4.  Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy.

Authors:  Massimo Donadelli; Ilaria Dando; Elisa Dalla Pozza; Marta Palmieri
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.

Authors:  Citadel J Cabasag; Melina Arnold; Mark Rutherford; Aude Bardot; Jacques Ferlay; Eileen Morgan; Alana Little; Prithwish De; Elijah Dixon; Ryan R Woods; Nathalie Saint-Jacques; Sue Evans; Gerda Engholm; Mark Elwood; Neil Merrett; David Ransom; Dianne L O'Connell; Freddie Bray; Isabelle Soerjomataram
Journal:  Br J Cancer       Date:  2022-03-02       Impact factor: 9.075

Review 6.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

7.  Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals.

Authors:  Gabriele Capurso; Marianna Signoretti; Roberto Valente; Urban Arnelo; Matthias Lohr; Jan-Werner Poley; Gianfranco Delle Fave; Marco Del Chiaro
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

8.  Is the New T1 Category as Defined in the Eighth Edition of the AJCC Pancreatic Cancer Staging System an Improvement?

Authors:  Wooil Kwon; Taesung Park; Jin He; Ryota Higuchi; Donghee Son; Seung Yeoun Lee; Jaeri Kim; Yoonhyeong Byun; Hongbeom Kim; Sun-Whe Kim; Christopher L Wolfgang; Masakazu Yamamoto; Jin-Young Jang
Journal:  J Gastrointest Surg       Date:  2019-12-10       Impact factor: 3.452

Review 9.  Radiomics in stratification of pancreatic cystic lesions: Machine learning in action.

Authors:  Vipin Dalal; Joseph Carmicheal; Amaninder Dhaliwal; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Cancer Lett       Date:  2019-10-17       Impact factor: 8.679

Review 10.  Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases.

Authors:  Y H Andrew Wu; Atsushi Oba; Laurel Beaty; Kathryn L Colborn; Salvador Rodriguez Franco; Ben Harnke; Cheryl Meguid; Daniel Negrini; Roberto Valente; Steven Ahrendt; Richard D Schulick; Marco Del Chiaro
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.